← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Fibronox, L.L.C.
Tucson, AZ
$2,580,478
Total funding
3
Grants
Funding over time
peak $1.2M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,580,478 · 3
By mechanism
R44$2,045,720 · 1
R41$534,758 · 2
Investigators at Fibronox, L.L.C.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Advanced Pre-clinical development of Nox4 inhibitors for Pulmonary Fibrosis$1,091,039
R44 · FY2025 · HL
Advanced Pre-clinical development of Nox4 inhibitors for Pulmonary Fibrosis$954,681
R44 · FY2024 · HL
Repurposing of FDA-approved Nrf2 Activators as a Novel Inhaled Therapy for Pulmonary Fibrosis$286,739
R41 · FY2024 · HL
Therapeutic targeting of Nox2 and Nox4 in Duchenne Muscular Dystrophy$248,019
R41 · FY2020 · HL